antibodytherapeutics.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:

Meta Tags

Title	Ab
Description	Development of Novel Multi-specific Antibody-Based Therapeutic Modalities for Cancer & Home Company Our Science Pipeline Contact Us 3541 Investment Blvd. Suite #2 Hayward, CA 94545, USA 510-397-6439 info@antibodytherapeutics.com Development
Keywords	N/A

Server Information

WebSite	antibodytherapeutics.com
Host IP	54.184.103.125
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

antibodytherapeutics.com Valuation

US$1,793,974

Last updated: 2023-05-17 11:46:50

antibodytherapeutics.com has Semrush global rank of 5,899,920. antibodytherapeutics.com has an estimated worth of US$ 1,793,974, based on its estimated Ads revenue. antibodytherapeutics.com receives approximately 206,997 unique visitors each day. Its web server is located in United States, with IP address 54.184.103.125. According to SiteAdvisor, antibodytherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,793,974
Daily Ads Revenue	US$1,656
Monthly Ads Revenue	US$49,680
Yearly Ads Revenue	US$596,152
Daily Unique Visitors	13,800
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
antibodytherapeutics.com. 3599	A	antibodytherapeutics.com. 3599	IP: 54.184.103.125
antibodytherapeutics.com. 21600	NS	antibodytherapeutics.com. 21600	NS Record: ns-cloud-d4.googledomains.com.
antibodytherapeutics.com. 21600	NS	antibodytherapeutics.com. 21600	NS Record: ns-cloud-d1.googledomains.com.
antibodytherapeutics.com. 21600	NS	antibodytherapeutics.com. 21600	NS Record: ns-cloud-d2.googledomains.com.
antibodytherapeutics.com. 21600	NS	antibodytherapeutics.com. 21600	NS Record: ns-cloud-d3.googledomains.com.
antibodytherapeutics.com. 3600	MX	antibodytherapeutics.com. 3600	MX Record: 1 aspmx.l.google.com.
antibodytherapeutics.com. 3600	MX	antibodytherapeutics.com. 3600	MX Record: 10 alt4.aspmx.l.google.com.
antibodytherapeutics.com. 3600	MX	antibodytherapeutics.com. 3600	MX Record: 10 alt3.aspmx.l.google.com.
antibodytherapeutics.com. 3600	MX	antibodytherapeutics.com. 3600	MX Record: 5 alt1.aspmx.l.google.com.
antibodytherapeutics.com. 3600	MX	antibodytherapeutics.com. 3600	MX Record: 5 alt2.aspmx.l.google.com.
antibodytherapeutics.com. 3600	TXT	antibodytherapeutics.com. 3600	TXT Record: v=spf1 include:_spf.google.com ~all

HtmlToTextCheckTime:2023-05-17 11:46:50

Home Company Our Science Pipeline Contact Us 3541 Investment Blvd. Suite #2 Hayward, CA 94545, USA 510-397-6439 info@antibodytherapeutics.com Development of Novel Multi-specific Antibody-Based Therapeutic Modalities for Cancer & Difficult-To-Treat Diseases Antibody Therapeutics Inc. develops next generation Multi-specific Therapeutic Antibodies with balanced safety, efficacy, and developability for the treatment of cancers and other difficult-to-treat diseases. We license Antibody Studio’s unique technology platform and incorporate Genor Biopharma’s unique CMC and Clinical Development experience to develop novel therapeutic antibodies. Antibody Therapeutics is a group of dynamic and passionate individuals from around the world working together to translate immunotherapy and alleviate the burden of patients suffering from severe diseases. We utilize our diverse academic, social, and cultural backgrounds to achieve this common goal. Antibody Studio Inc. We envision the use of Antibody

HTTP Headers

HTTP/1.1 301 Moved Permanently
Connection: Keep-Alive
Keep-Alive: timeout=5, max=100
content-type: text/html; charset=UTF-8
x-pingback: http://www.antibodytherapeutics.com/xmlrpc.php
x-redirect-by: WordPress
location: https://www.antibodytherapeutics.com/
date: Thu, 24 Mar 2022 09:00:34 GMT
server: LiteSpeed
vary: User-Agent

HTTP/2 200 
content-type: text/html; charset=UTF-8
x-pingback: https://www.antibodytherapeutics.com/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
date: Thu, 24 Mar 2022 09:00:35 GMT
server: LiteSpeed
vary: User-Agent
alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"

antibodytherapeutics.com Whois Information

Domain Name: ANTIBODYTHERAPEUTICS.COM
Registry Domain ID: 2021901825_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.google.com
Registrar URL: http://domains.google.com
Updated Date: 2019-10-05T22:17:59Z
Creation Date: 2016-04-15T18:43:31Z
Registry Expiry Date: 2022-04-15T18:43:31Z
Registrar: Google LLC
Registrar IANA ID: 895
Registrar Abuse Contact Email: registrar-abuse@google.com
Registrar Abuse Contact Phone: +1.8772376466
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-CLOUD-D1.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D2.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D3.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D4.GOOGLEDOMAINS.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-03-24T09:28:52Z <<<

antibodytherapeutics.com valuation and analysis